Agilon Health faces a class action lawsuit over allegedly false 2025–2026 financial claims that misled investors.

A class action lawsuit has been filed against Agilon Health, Inc. (NYSE: AGL) and some of its officers, alleging they made false or misleading statements about the company’s business and financial outlook from February 26, 2025, to August 4, 2025. The complaint claims executives issued overly optimistic 2026 guidance despite knowing it was unachievable due to industry challenges and exaggerated the benefits of risk-reduction strategies. Investors who bought Agilon stock during that period may join the case, with the deadline to request lead plaintiff status set for March 2, 2026. The law firm Bronstein, Gewirtz & Grossman, LLC is handling the case on a contingency fee basis.